Nearly half of all participants achieved at least 25% weight loss, and a meaningful portion exceeded 30% or even 35%
Innovative Solutions: Discover how sponsors can support sites through flexibility and innovative protocol design, and how sites can support sponsors through robust enrollment and retention programs Case Studies and Best Practices: Learn about recent real-world scenarios and best practices for successfully navigating the challenges of developing GLP-1s from bench to bedside, and what lessons can be applied to your own studies
Pharmacogn Mag 11(41):74 Frk W, Wojtasiska A, Lisiska W, Mynarska E, Franczyk B, Rysz J (2022) Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease
Also in the DURATION trial, exenatide weekly had beneficial reductions of -3 to -5mm Hg in systolic blood pressure 6
We used the model to investigate the effect of the timing of N-acetylcysteine (NAC) rescue
10,27 Management The management of DJS is supportive and does not require specific therapy